drugset / Trial / NCT02366377
The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of 3 different doses of SHR3824 compared with placebo in patients with type 2 diabetes mellitus who are receiving treatment with metformin monotherapy (ie, treatment with a single drug) and have inadequate glycemic (blood sugar) control.
Timeline
- Start
- 2015-02
- Primary completion
- 2016-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Henagliflozin | Small molecule | 5 mg | — |
| Subject | Henagliflozin | Small molecule | 10 mg | — |
| Subject | Henagliflozin | Small molecule | 20 mg | — |
| Background | Metformin | Small molecule | 500 mg | — |